Winning Stock Forecast: ENDP Returns up to 30.67% in 1 Month with global expansion and counter lawsuits

“One of the biggest challenges to medicine is the incorporation of information technology in our practices.”

– Samuel Wilson

(Source: Air Force Medical Service)

Endo International plc, incorporated on October 31, 2013, is a generics and specialty branded pharmaceutical company. The company has three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has its own brand names and its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics

Read More

FMI Stock Forecast: Foundation Medicine Rallies As Acquisition Announced

  This article was written by Julia Masch, a Financial Analyst at I Know First.



  Highlights

  • Roche’s Acquisition of Foundation
  • The Future of Foundation
  • Current Bullish I Know First Forecast For FMI
 

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

Winning HRTX Stock Forecast: Heron Therapeutics Gained 46.99% 3 Months After Strong Bullish Signal

“HTX-011 is the only long-acting local anesthetic to demonstrate significantly reduced postoperative pain and opioid use through 72 hours compared to bupivacaine solution, the standard-of-care local anesthetic for postoperative pain management, in Phase 3 studies. We look forward to working towards the submission of an NDA to the FDA for HTX-011 in the second half of 2018.”

– Barry D. Quart, Pharm.D., CEO of Heron Therapeutics.

(Source: smarteranalyst.com)

Just in three months from March 25th, 2018, Heron Therapeutics Inc (NYSE: HRTX) has gained 46.99%. The main reason for

Read More

Quick Win By The Algorithm: XOMA Reaches Agreement with Novartis, Stock Soars

Stock Prediction Quick Win

Read The Full Forecast

quick win

Stock Market Outlook Quick Win by the Algorithm: FDA Approval Expedites OMER’s Growth

Quick Win by the Algorithm

Read The Full Forecast

quick win

Quick Win by the Algorithm: Positive Outlook for Achillion

Quick Win by the Algorithm

Read The Full Forecast

Biopharm Stock Prediction: KERX Developing New Ways to Treat Patients With CKD

This article was written by Blair Goldenberg, a Financial Analyst at I Know First, and enrolled in a Masters of Finance at Colorado State University.

Biopharm Stock Prediction

Summary
  • Background on Keryx Biopharmaceuticals (KERX)
  • KERX Stock Analysis
  • KERX Helping Patients Around the US
  • I Know First Algorithm Bullish Forecast For KERX

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here